20-08-2012

The Renewable Fuel Standard provides the fundamental foundation driving private investment in America’s advanced biofuels industry. The Biotechnology Industry Organization (BIO) responded to formal requests by Gov. Bev Perdue (D-N.C.) and Gov. Mike Beebe (D-Ark.) that the Environmental ...

more

08-01-2008

Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood issued the following statement commemorating the 25th anniversary of the Orphan Drug Act. This landmark law helped lead to the development of new drugs and biologics for rare and frequently untreated diseases by ...

more

07-08-2007

Jim Greenwood, president and CEO of the Biotechnology Industry Organization (BIO), thanked U.S. Representatives Allyson Schwartz (D-PA) and Kevin Brady (R-TX) for their leadership in introducing the American Life Sciences Competitiveness Act of 2007 (H.R. 3264). "America's life sciences ...

more

Patenting is a Critical Element in Fostering Research and Development

04-06-2007

The theory claiming that the over-patenting of biotechnology research hinders the research and development of new treatments is not supported by empirical evidence, concludes a white paper entitled "The Myth of the Anticommons" released by the Biotechnology Industry Organization (BIO). The ...

more

More Competition Would Allow Funding of Better Science

30-04-2007

Dr. Gary McGarrity, Executive Vice President of Scientific and Clinical Affairs at VIRxSYS, testified on behalf of the Biotechnology Industry Organization (BIO) before the House Science and Technology Subcommittee on Technology and Innovation regarding the reauthorization of the Small ...

more

20-04-2007

he following statement was issued by Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood regarding the Patent Reform Act of 2007, introduced by Senators Patrick Leahy (D-VT) and Orrin Hatch (R-UT) and Congressmen Howard Berman (D-CA) and Lamar Smith (R-TX): "BIO ...

more

13-04-2007

Earlier this week, the Biotechnology Industry Organization (BIO) relocated their headquarters to Southwest Washington, D.C. "This new location meets the needs of our growing organization," stated BIO President and CEO Jim Greenwood. "Our growth reflects the maturation and expansion of the ...

more

12-04-2007

The widening use of new, innovative biopharmaceutical treatments for diseases, such as cancer, multiple sclerosis and heart disease, will have a limited impact on healthcare costs for private healthcare payers over the next several years, according to an independent study released by the ...

more

22-02-2007

The Biotechnology Industry Organization (BIO) announced the election of Pfizer Chairman and CEO Jeffrey B. Kindler to BIO's Board of Directors. Kindler will replace Pfizer Vice President of Corporate Policy and Strategic Management Fred Telling, who had served on the BIO Board for eleven ...

more

Commends President for Proposed Funding Increases to FDA, Pandemic Preparedness and Biodefense Countermeasures

13-02-2007

The Biotechnology Industry Organization (BIO) praised the proposed budget for FY2008 announced by President Bush as a good starting point and urged Congress to further increase funding for the Food and Drug Administration (FDA). "It is critical to ensure that the FDA has the resources ...

more